Cary Street Partners Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.89M | Buy |
24,742
+71
| +0.3% | +$14K | 0.64% | 40 |
|
|
2024
Q2 | $4.23M | Buy |
24,671
+908
| +4% | +$156K | 0.62% | 38 |
|
|
2024
Q1 | $4.33M | Buy |
23,763
+118
| +0.5% | +$21.5K | 0.67% | 39 |
|
|
2023
Q4 | $3.66M | Sell |
23,645
-1,080
| -4% | -$167K | 0.63% | 44 |
|
|
2023
Q3 | $3.69M | Sell |
24,725
-541
| -2% | -$80.6K | 0.69% | 42 |
|
|
2023
Q2 | $3.4M | Sell |
25,266
-334
| -1% | -$45K | 0.63% | 43 |
|
|
2023
Q1 | $4.08M | Sell |
25,600
-720
| -3% | -$115K | 0.77% | 35 |
|
|
2022
Q4 | $4.25M | Buy |
26,320
+591
| +2% | +$95.5K | 0.86% | 30 |
|
|
2022
Q3 | $3.45M | Sell |
25,729
-3,010
| -10% | -$404K | 0.83% | 29 |
|
|
2022
Q2 | $4.4M | Sell |
28,739
-12,176
| -30% | -$1.87M | 1.03% | 26 |
|
|
2022
Q1 | $6.63M | Buy |
40,915
+427
| +1% | +$69.2K | 1.32% | 16 |
|
|
2021
Q4 | $5.48M | Sell |
40,488
-7,390
| -15% | -$1M | 1.17% | 25 |
|
|
2021
Q3 | $5.17M | Sell |
47,878
-1,293
| -3% | -$139K | 1.82% | 16 |
|
|
2021
Q2 | $5.54M | Sell |
49,171
-206,538
| -81% | -$23.3M | 1.32% | 20 |
|
|
2021
Q1 | $5.72M | Buy |
255,709
+8,837
| +4% | +$198K | 1.41% | 14 |
|
|
2020
Q4 | $5.63M | Buy |
+246,872
| New | +$5.63M | 1.66% | 6 |
|